T1	Concept 452 471	SARS-CoV 3a protein
T2	Concept 631 641	SARS-CoV-2
T3	Concept 693 695	R0
T4	Concept 624 626	R0
T5	Concept 710 727	betacoronaviruses
T6	Concept 834 848	SARS-CoV S-RBD
T7	Concept 852 856	ACE2
T8	Action 789 796	reaches
T9	Concept 773 788	2019-nCoV S-RBD
T10	Concept 363 371	SARS-CoV
T11	Action 379 390	transmitted
T12	Concept 399 418	sexual transmission
A1	Uncertain T10
R1	subject Arg1:T11 Arg2:T10	
R2	target Arg1:T11 Arg2:T12	
T13	Concept 492 516	expression of fibrinogen
T14	Action 479 487	regulate
R4	subject Arg1:T14 Arg2:T1	
R5	target Arg1:T14 Arg2:T13	
T15	Concept 520 524	lung
T16	Concept 525 541	epithelial cells
R3	has-part Arg1:T15 Arg2:T16	
R6	in-place Arg1:T13 Arg2:T15	
T17	Concept 103 117	infection case
T18	Action 122 130	decrease
T19	Concept 145 154	new cases
T20	Concept 189 229	first (second) week in the February 2-15
R9	target Arg1:T18 Arg2:T19	
R10	subject Arg1:T18 Arg2:T17	
R11	in-time Arg1:T18 Arg2:T20	
T21	Concept 66 80	COVID-19 cases
T22	Concept 56 65	confirmed
R12	has-property Arg1:T21 Arg2:T22	
T23	Action 81 89	suggests
R13	subject Arg1:T23 Arg2:T21	
T24	Concept 50 55	newly
R15	has-property Arg1:T21 Arg2:T24	
R16	subject Arg1:T8 Arg2:T9	
T25	Concept 814 830	binding strength
T27	Concept 589 620	amplitude of seasonal variation
T28	Concept 654 689	amplitude of the seasonal variation
R18	has-property Arg1:T5 Arg2:T28	
R19	in-context Arg1:T27 Arg2:T4	
R21	in-context Arg1:T28 Arg2:T3	
T26	Concept 544 562	seasonality factor
T29	Action 570 579	indicates
R7	subject Arg1:T29 Arg2:T26	
R8	has-property Arg1:T6 Arg2:T25	
R17	target Arg1:T8 Arg2:T6	
R14	target Arg1:T23 Arg2:T18	
T30	Concept 645 649	half
T31	Concept 429 436	studies
T32	Action 441 446	shown
R22	subject Arg1:T32 Arg2:T31	
R25	target Arg1:T32 Arg2:T14	
R26	is-a Arg1:T2 Arg2:T5	
R23	has-property Arg1:T2 Arg2:T27	
R20	target Arg1:T29 Arg2:T2	
R24	has-property Arg1:T27 Arg2:T30	
R27	in-context Arg1:T6 Arg2:T7	
